Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

AusPAR: Selexipag

Australian Public Assessment Report

AusPAR

AusPAR: Selexipag [PDF, 1.57 MB]

AusPAR: Selexipag [DOCX, 1.96 MB]

Attachment: Product Information: Selexipag [PDF, 1018.91 KB]

Attachment: Product Information: Selexipag [DOCX, 840.63 KB]

Attachment: Extract from Clinical Evaluation Report: Product Information: Selexipag [PDF, 5.04 MB]

Attachment: Extract from Clinical Evaluation Report: Product Information: Selexipag [DOCX, 10.18 MB]

Device/Product Name

Uptravi

Active ingredients

Selexipag

AusPAR Date

8 November 2016

Published

17 November 2016

Submission Number

PM-2014-04586-1-3

Submission Type

New chemical entity

Decision

Approved

Product types

Prescription medicines